- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 7th, 2007
Nanoparticles - manufactured particles on the scale of atoms and molecules - are being developed to deliver drugs directly to cancer cells in the brain.
Right now, this system has been tested only on mice. Clinical trials involving people could begin within three years.
In order for most cancer drugs to be effective in the brain, they have to be administered in large doses. These toxic drugs kill the cancerous cells, but they also destroy healthy cells surrounding the tumor. Using nanotechnology, James Connor at Penn State University has devised a way to deliver smaller doses of drugs that target just cancerous cells using what's known as a "lipid-based nanoparticle."
|Related News Press|
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Personal cooling units on the horizon April 29th, 2016
Exploring phosphorene, a promising new material April 29th, 2016
Researchers create a first frequency comb of time-bin entangled qubits: Discovery is a significant step toward multi-channel quantum communication and higher capacity quantum computers April 28th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016
UCLA nanoscientists engage shoppers in fun conversations March 8th, 2016
Risk Analysis Publishes Non-Animal Strategy to Assess Nanomaterials February 24th, 2016